The global biosimulation market size is expected to reach USD 10.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 17.0% from 2025 to 2030. The key factors fueling the market growth include the increasing incidence of chronic diseases, increase in healthcare digitization, and usage of biosimulation solutions in...

The global clinical trials market reached a valuation of USD 80.7 billion in 2023, with an expected compound annual growth rate (CAGR) of 6.49% from 2024 to 2030. A significant increase in market growth was observed in 2020 due to the COVID-19 pandemic, impacting both virtual and traditional clinical trials. Many pharmaceutical and biotech companies prioritized novel drug development in...

The clinical trial supplies market is a crucial segment of the pharmaceutical and biotechnology industries. It encompasses the management and provision of materials necessary for conducting clinical trials. This market is integral to the development of new drugs, medical devices, and therapies, ensuring that these trials run smoothly and efficiently. The demand for clinical trial supplies...

The global investigational new drug CDMO market size is expected to reach USD 7.79 billion by 2030, registering a CAGR of 6.9% during the forecast period, according to a new report by Grand View Research, Inc. This is largely due to the increased R&D investments, along with stringent regulations pertaining to IND. The U.S. FDA and the European Medicines Agency (EMA) are health...

Behind every promising new drug on the verge of changing lives is a critical partner many don’t hear about The behind-the-scenes powerhouse accelerating innovation and transforming the drug development landscape is the contract development and manufacturing organization specializing in investigational new drugs These specialized companies are the unsung heroes in the race to bring...